Peripheral neuropathy (PN) is a complex, multifaceted disorder that requires a meticulous and systematic approach for effective management. This guide will offer a comprehensive overview of the evaluation process for PN, aiding medical practitioners in their diagnostic journey.
PN is characterized by damage to the peripheral nerves, resulting in a variety of symptoms, such as numbness, pain, and weakness, predominantly in the hands and feet. It can occur due to numerous causes including diabetes, infections, genetic disorders, and exposure to toxins.
History taking and physical examination form the cornerstone of PN evaluation. Key elements of the history include symptom onset, progression, and distribution. Physical examination should focus on assessing sensory and motor functions, reflexes, and the presence of any autonomic symptoms.
Lab tests, including complete blood count, glucose levels, renal and liver function tests, and vitamin B12 levels, can help identify underlying systemic conditions. Electrophysiological studies, such as nerve conduction studies and electromyography, can confirm the diagnosis and provide information about the extent and type of nerve damage.
When the diagnosis remains unclear after initial evaluation, advanced diagnostic tools may be employed. These include skin biopsy for intraepidermal nerve fiber density measurement, and corneal confocal microscopy for corneal nerve fiber assessment.
PN presents a diagnostic challenge due to its diverse etiologies and clinical presentations. A systematic approach that starts with a thorough history and physical exam, followed by judicious use of lab tests and electrophysiological studies can help decipher the maze. Advanced diagnostic tools can further aid in the evaluation when initial investigations are inconclusive. By understanding this comprehensive guide, medical practitioners can enhance their diagnostic accuracy and improve patient outcomes in PN.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation